Literature DB >> 6140158

Human pancreatic growth hormone releasing factor (hpGRF-1-40) stimulates GH release in the ovine fetus.

E Ohmura, A Jansen, V Chernick, J Winter, H G Friesen, J Rivier, W Vale.   

Abstract

The effects of growth hormone-releasing factor, hpGRF (1-40), on plasma GH levels were studied in chronically catheterized ovine fetuses between 71 to 134 days of gestation. The basal ovine (o) GH levels in the fetus ranged between 41 - 144 ng/ml, while values in the ewe were often less than 6 ng/ml. hpGRF (1-40), 5 micrograms/kg infused into a fetal vein, markedly stimulated GH release in all nine fetuses. The maximum increase above pretreatment levels (net increases) ranged from 65 ng/ml to 498 ng/ml, with a mean net increase of 229 ng/ml. The responses of oGH in fetuses at younger gestational age appeared to be greater than in older fetuses. Mean plasma oPRL did not change after hpGRF infusion. These results indicate that somatotrophs in fetal sheep in mid- and late gestation have receptors for GRF, and GH secretion may be modulated by GRF at this stage of gestation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6140158     DOI: 10.1210/endo-114-1-299

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  1 in total

1.  Synthetic human growth hormone releasing factor (h-GRF-I-44-NH2) dose response effect on growth hormone and prolactin secretion in healthy adult men.

Authors:  J P Boissel; R Cohen; S Biot-Laporte; B Claustrat; H Renard; M Olivier; G Sassolas
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.